Showing results (1-10 of 48) with videos related to
Sort By:
Pageof 5
La Revue Du Praticien|June 23, 2021
[What are the optimal strategies for treating schizophrenia?]Olivier GuillinInternational Review of Neurobiology|March 14, 2007
Brain-derived neurotrophic factor in schizophrenia and its relation with dopamineOlivier Guillin, Caroline Demily, Florence ThibautInternational Review of Neurobiology|March 14, 2007
Neurobiology of dopamine in schizophreniaOlivier Guillin, Anissa Abi-Dargham, Marc LaruelleJournal of Molecular Neuroscience : MN|January 5, 2024
One Train May Hide Another: Two Cases of Co-Occurring Primary Familial Brain Calcification and Alzheimer's DiseaseAndrea Timmi, Alexandre Morin, Olivier Guillin, et al.General Hospital Psychiatry|July 17, 2010
Charles Bonnet syndrome and vitamin B12 deficiency: a case reportValérie Bourgeois, Marie Desbordes, Mathieu Follet, et al.Molecular Biology of the Cell|September 10, 2004
GIPC recruits GAIP (RGS19) to attenuate dopamine D2 receptor signalingFreddy Jeanneteau, Olivier Guillin, Jorge Diaz, et al.Frontiers in Psychiatry|June 20, 2025
High frequency repetitive transcranial magnetic stimulation for auditory verbal hallucinations in schizophrenia-spectrum disorders: a naturalistic studyVirginie Moulier, Charlotte Lemonnier, Sonia Dollfus, et al.L'Encephale|June 21, 2021
[Electroconvulsive therapy during the perinatal period: Representations of mental health professionals]Noémie Nard, Virginie Moulier, Dominique Januel, et al.Neurotoxicity Research|April 24, 2003
Brain-derived neurotrophic factor controls dopamine D3 receptor expression: implications for neurodevelopmental psychiatric disordersPierre Sokoloff, Olivier Guillin, Jorge Diaz, et al.Pageof 5